| 标题 |
213eTiP First-line oral vinorelbine plus furmonertinib in refractory epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC): A multicenter, non-randomized, two-cohort study |
| 网址 | |
| DOI | |
| 其它 |
期刊:ESMO Open 作者:B. Zhang; Y. Zhang; C. Shi; Z. Gao; R. Zhong; et al 出版日期:2026 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)